حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Thyrocare Technologies Limited
THYROCAREThyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited. Address: D/37-3, TTC Industrial Area, Navi Mumbai, India, 400703
Analytics
سعر الهدف في وول ستريت
66 195.67 INRنسبة السعر إلى الأرباح
59.8829العائد الربحي
1.86 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية THYROCARE
تحليلات الأرباح THYROCARE
نمو الأرباح على مدى 5 سنوات
80 %النمو المستمر
1 سنةمعدل الدفع 5 سنوات في المتوسط
96 %تاريخ الأرباح THYROCARE
تقييم الأسهم THYROCARE
المالية THYROCARE
نتائج | 2019 | ديناميات |